Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (41)

2024

  1. Exposición prolongada a la televisión en niños y adolescentes: efectos sobre la salud y estrategias de protección

    Revista espanola de salud publica, Vol. 98

  2. Inflammatory and Cardiovascular Biomarkers to Monitor Fabry Disease Progression

    International Journal of Molecular Sciences, Vol. 25, Núm. 11

  3. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

    Frontiers in Pharmacology, Vol. 15

2023

  1. A murine model of BSCL2-associated Celia's encephalopathy

    Neurobiology of Disease, Vol. 187

  2. Morphological Hallmarks of Classical Fabry Disease: An Ultrastructural Study in a Large Spanish Family

    Journal of Clinical Medicine, Vol. 12, Núm. 17

  3. Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 20

  4. SATB2 as a Marker of the Proximal Nephron: Expression in Nephrogenic Adenoma and Correlation With Other Renal Tubular Markers

    Applied Immunohistochemistry and Molecular Morphology, Vol. 31, Núm. 3, pp. 145-153

  5. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

2022

  1. Parkinson's disease and diabetes mellitus: Common mechanisms and treatment repurposing

    Neural Regeneration Research, Vol. 17, Núm. 8, pp. 1652-1658

2021

  1. Assessment of biological matrices for the detection of in utero cannabis exposure

    Drug Testing and Analysis, Vol. 13, Núm. 7, pp. 1371-1382

  2. Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists

    Frontiers in Neuroendocrinology, Vol. 62

  3. Meconium and maternal hair analysis vs. medical records to monitor antidepressants and benzodiazepines exposure during pregnancy

    Forensic Toxicology, Vol. 39, Núm. 2, pp. 417-426

2020

  1. Assessment of tobacco exposure during pregnancy by meconium analysis and maternal interview

    Journal of Analytical Toxicology, Vol. 44, Núm. 8, pp. 797-802

  2. Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy

    Journal of Addictive Diseases, Vol. 39, Núm. 2, pp. 175-182

2019

  1. Detection of in utero ethanol exposure via ethyl glucuronide and ethyl sulfate analysis in umbilical cord and placenta

    Forensic Toxicology, Vol. 37, Núm. 1, pp. 90-103

  2. The effect of copy number variations in chromosome 16p on body weight in patients with intellectual disability

    Journal of Human Genetics, Vol. 64, Núm. 3, pp. 221-231

2017

  1. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy

    Drug Testing and Analysis, Vol. 9, Núm. 6, pp. 898-904

2015

  1. Síndrome de anton secundario a necrosis occipital por intoxicación aguda con metanol

    Revista de Neurologia

2014

  1. Preclinical screening for retinopathy of prematurity risk using IGF1 levels at 3 weeks post-partum

    PLoS ONE, Vol. 9, Núm. 2

2013

  1. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection

    Therapeutic Drug Monitoring, Vol. 35, Núm. 4, pp. 502-509